Industry News

You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

Bayer switches Astepro Allergy to OTC status in US
Premium

18 June 2021

The US Food and Drug Administration (FDA) has approved the switch of Astepro (azelastine hydrochloride 0.15%) from prescription-to-OTC status. Bayer said its Astepro Allergy Nasal Spray would be available at national mass retail locations in the first quarter of 2022.

Read the full story

Almost one in three Europeans taking more VMS
Premium

18 June 2021

Almost one in three Europeans, 29%, are taking vitamins, minerals and supplements (VMS) more often than usual during the COVID-19 pandemic, according to the Stada Health Report 2021, with women more likely than men to step up their intake of VMS products.

Read the full story